REFRACTORY GLIOBLASTOMA
Clinical trials for REFRACTORY GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for REFRACTORY GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental dual therapy targets Hard-to-Treat brain tumors
Disease control OngoingThis early-phase study tests a combination of two treatments for glioblastoma that has returned or not responded to standard therapy. The approach uses specially engineered immune cells (CAR T cells) designed to attack the tumor, along with drugs that boost the immune system's ab…
Matched conditions: REFRACTORY GLIOBLASTOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 17, 2026 05:31 UTC
-
Last-Resort drug opens for brain cancer patients
Disease control NO_LONGER_AVAILABLEThis program provides gallium maltolate, an experimental oral drug, to adults with glioblastoma that has come back or not responded to standard treatments. It is for patients who have run out of other options and may still benefit. The goal is to control the disease, not cure it.
Matched conditions: REFRACTORY GLIOBLASTOMA
Sponsor: Imaging Biometrics, LLC • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
Engineered immune cells take on deadly brain tumors
Disease control OngoingThis early-phase study tests a new immunotherapy for people with malignant glioma that has returned or not responded to standard treatment. Researchers take a patient's own T-cells (a type of immune cell), add a gene that helps them recognize and attack glioma cells, and infuse t…
Matched conditions: REFRACTORY GLIOBLASTOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 04, 2026 16:23 UTC